Johnson Matthey PLC
LSE:JMAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson Matthey PLC
LSE:JMAT
|
UK |
|
Outlook Therapeutics Inc
NASDAQ:OTLK
|
US |
|
Fiserv Inc
NASDAQ:FISV
|
US |
|
Dnb ASA
OTC:DNBBY
|
NO |
|
C
|
Cal-Maine Foods Inc
F:CM2
|
US |
|
DTE Energy Co
NYSE:DTE
|
US |
|
T
|
Tenaris SA
XBER:TW11
|
LU |
|
I
|
IPD Group Ltd
ASX:IPG
|
AU |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
|
Roche Holding AG
OTC:RHHBF
|
CH |
|
Koninklijke Philips NV
NYSE:PHG
|
NL |
|
X
|
Xinhua Winshare Publishing and Media Co Ltd
SSE:601811
|
CN |
|
Bytes Technology Group PLC
OTC:BYITY
|
UK |
|
Maple Leaf Foods Inc
TSX:MFI
|
CA |
|
O
|
Ocean Bio-Chem Inc
F:OBC
|
US |
|
B
|
Beforepay Group Ltd
ASX:B4P
|
AU |
Wall St Price Targets
JMAT Price Targets Summary
Johnson Matthey PLC
According to Wall Street analysts, the average 1-year price target for JMAT is 2 270.23 GBX with a low forecast of 1 919 GBX and a high forecast of 2 709 GBX.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JMAT's stock price target?
Price Target
2 270.23
GBX
According to Wall Street analysts, the average 1-year price target for JMAT is 2 270.23 GBX with a low forecast of 1 919 GBX and a high forecast of 2 709 GBX.
What is the Revenue forecast for Johnson Matthey PLC?
Projected CAGR
-18%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is -18%.
What is the Operating Income forecast for Johnson Matthey PLC?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been -1%. The projected CAGR for the next 8 years is -2%.
What is the Net Income forecast for Johnson Matthey PLC?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 2%.
